Protide Pharmaceuticals

Events

Alec Polovina — Tue, 22 Aug 2023 16:15:40 +0000

May 29^th— June 1^st

September 8^th— 10^th

May 4^th— 7^th

May 26^th— 28^th

May 27^th— 30^th

July 21^st— 24^th

Protide Receives ISO 13485:2016 Certification

ExcalTech — Tue, 22 Aug 2023 15:19:14 +0000

Protide Receives ISO 13485:2016 Certification

Protide Pharmaceuticals is proud to announce we have been certified by Eagle Registrations, an ANSI board accredited certification body, for ISO 13485:2016 quality management system. This certification servers as a commitment to our customers and further strengthens Protide’s quality systems.

Protide Announces Distribution Agreement with VWR International LLC

Alec Polovina — Wed, 30 Sep 2020 13:00:59 +0000

Distribution Agreement with VWR International LLC

Protide Pharmaceuticals, Inc. is pleased to announce we have completed a distribution agreement with VWR International LLC, an Avantor, Inc. company.

Protide is excited to support VWR’s life science catalog with our Characterized Cell Growth, Cell Processing, and Cryopreservation solutions.

Protide Celebrates 40 Years

Alec Polovina — Tue, 18 Aug 2020 14:00:31 +0000

Protide Celebrates 40 Years

Protide Pharmaceuticals, Inc. is excited to celebrate our 40^th anniversary.

Since our inception, Protide has been at the forefront of Characterized Cell Growth and cryopreservation technologies. Protide pioneered Characterized Cell Growth Solutions 40 years ago when our serum-free technology was introduced.

Protide continues to recognize the importance of our technology and product quality in cell therapy, regenerative medicine, vaccine production and basic research.

To our customers, we assure you of our continued service and dedication. We are indebted to your loyal support and the use of Protide products. We are energized for another 40 years of excellence.

Growing Solutions For Cell Technology

Automated leukapheresis cryopreparation using Protide’s 2-8CELLsius

Alec Polovina — Thu, 28 May 2020 13:00:13 +0000

Automated leukapheresis cryopreparation using Protide's 2-8CELLsius

2-8CELLsius and 2-8CELLsius + DMSO utilized in Fresenius Kabi study. Please click to read more on the Cytotherapy Journal website.

2-8CELLsius™ alternative packaging options

Alec Polovina — Mon, 23 Mar 2020 14:50:31 +0000

2-8CELLsius alternative packaging

Protide Pharmaceuticals, Inc. is excited to announce alternative packaging options for 2-8CELLsius (Cell washing/Short-term storage) and 2-8CELLsius + DMSO (Cryopreservation). Both products are now available in 1L media exchange bags for cellular processing devices.

A DMF is in process for both products to facilitate IND/NDA submissions. Please contact us at protide@protidepharma.com or call at 1-800-552-3569.

View our Product Catalog:

2-8CELLsius (Cell washing/Short-term storage)

2-8CELLsius + DMSO (Cryopreservation)